Aptis PRUJ Prosthesis for the Treatment of Patients With Proximal Radial Ulna Joint Disorders.

NCT ID: NCT05796908

Last Updated: 2025-11-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

84 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-04-12

Study Completion Date

2030-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A Prospective, Multi-Center, Single-Arm Clinical Trial of the safety and effectiveness of the Aptis PRUJ prosthesis for the treatment of patients with proximal radial ulna joint disorders

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a prospective, multi-center, single-arm clinical trial of the safety and effectiveness of the Aptis PRUJ prosthesis for the treatment of patients with proximal radial ulna joint disorders. A total of 84 patients will be enrolled in this trial with 9 centers participating in the US. The total study duration will be approximately 36 months, with an enrollment period of 12 months, followed by a 24 month follow-up period. Annual visits will continue until the last patient reaches the 2-year post-operative time point.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Arthritis Unstable Radial Head Proximal Radioulnar Joint Instability Decreased Motion at the Proximal Radioulnar Joint and/or the Radio-humeral Joint

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Aptis PRUJ Prothesis

Investigational Aptis PRUJ Prothesis treatment

Group Type EXPERIMENTAL

Aptis PRUJ Prosthesis

Intervention Type DEVICE

A prosthetic implant for replacement of the proximal radial ulna joint.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Aptis PRUJ Prosthesis

A prosthetic implant for replacement of the proximal radial ulna joint.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* In order to be eligible to participate in this study, subjects must meet all of the following criteria:

1. Patient is skeletally mature and under 85 years of age.
2. Patient has a painful, unstable radial head due to degeneration or post-traumatic disabilities presenting pain, crepitation, and decreased motion at the radiohumeral and/or proximal radioulnar joint and is otherwise
3. Patients willing and able to understand and sign the informed consent. In the opinion of the Investigator, the patient has the understanding and willingness to comply with all study requirements including the post-operative rehabilitation and follow-up visits per protocol.

Exclusion Criteria

* 1\. Inadequate bone stock or soft tissue coverage 2. Patients with severe humeral/ulnar arthritis, defined as:

1. Pain at terminal flexion/extension
2. Pain throughout ROM with loss of motion in terminal flexion and/or extension 3. Patients with an allergy to the implant materials 4. Active systemic infection or infection at the site of surgery 5. Physical interference with or by other prostheses during implantation or use 6. Have a Body Mass Index (BMI) greater than 35 kg/m2 7. Have any mental or psychological disorder that would impair the ability to complete the study questionnaires 8. Have significant comorbidities or conditions associated with high-risk for surgical or anesthetic survival (e.g., renal failure, peripheral vascular disease, unstable cardiac disease, poorly controlled diabetes, immunosuppression, etc.) 9. Have any medical condition or other circumstances that might interfere with the ability to return for follow-up visits in the judgment of the Investigator, including any systemic illness, neuromuscular, neurosensory, or musculoskeletal deficiency that would render the subject unable to perform appropriate post-operative rehabilitation 10. Have any condition which, in the judgment of the Investigator, would preclude adequate evaluation of the device's safety and performance 11. Skin, bone, circulatory and/or neurological deficiency at or affecting the implantation site 12. Prisoners 13. Patients on chronic corticosteroid or non-steroidal anti-inflammatory therapy 14. Women who are pregnant or breast-feeding or are planning to become pregnant during the study.

15\. Patients with a documented history of uncontrolled diabetes. 16. Patients with known allergies against anesthesia. 17. Patients with a history of or current drug and/or alcohol abuse 18. Patients unlikely to cooperate or are legally incompetent. 19. Patients with legal involvement, including an active claim for workman's compensation, or any other issue that would hinder completion of the two-year follow period.

20\. Patients who are participating or have participated in any other study involving an investigational drug or device within the past 3 months.


Subjects who meet any of the following intra-operative screening criteria will be excluded from participation in this study:
* A proximal radio ulnar joint that cannot be reduced intraoperatively
* Inadequate bone quality that would allow for implant placement
* Not enough radius bone proximally for device implantation
Minimum Eligible Age

18 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

MCRA

INDUSTRY

Sponsor Role collaborator

Aptis Medical

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

John Scheker

Role: STUDY_CHAIR

Aptis Medical

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Indiana Hand to Shoulder Center

Carmel, Indiana, United States

Site Status RECRUITING

Kleinert Kutz Hand Care Center

Louisville, Kentucky, United States

Site Status RECRUITING

Massachusetts General Hospital

Boston, Massachusetts, United States

Site Status RECRUITING

Orthopedic Associates of Southwest Ohio

Dayton, Ohio, United States

Site Status RECRUITING

Lehigh Valley Health Network

Allentown, Pennsylvania, United States

Site Status RECRUITING

University of Pennsylvania Perelman School of Medicine

Philadelphia, Pennsylvania, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Grace Montes

Role: CONTACT

5716747734

Stacy Gardner

Role: CONTACT

+44 7345 02 3334

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Copp

Role: primary

317-872-6819

Ann Jerde

Role: primary

502-852-5251

John Fitzhenry

Role: primary

617-726-1569

Laura Peterson

Role: primary

937-439-6483

Danielle Koehler

Role: primary

610-402-1657

Mounika Ponakala

Role: primary

215-273-5062

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AP-PRO-001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Active Knee Prosthesis Study
NCT06700668 ACTIVE_NOT_RECRUITING NA
Neuromusculoskeletal Interface for Bionic Arms
NCT07032753 NOT_YET_RECRUITING NA
Perform Humeral System Study
NCT05067543 RECRUITING